Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Minnesota Wild Goalie Harding Diagnosed With Multiple Sclerosis

Nov. 29 (Bloomberg) -- Minnesota Wild goaltender Josh Harding has been diagnosed with multiple sclerosis, the National Hockey League team said.

Harding, 28, is undergoing treatment for the disease.

“Our thoughts and prayers are with Josh and his family,” Wild General Manager Chuck Fletcher said in a statement on the team’s website. “Josh’s competitive fire has led him to a successful career in the NHL and we know he will approach this new battle in the same manner.”

Harding has played parts of six seasons with Minnesota and signed a three-year contract extension in June. After missing the 2010-11 due to a knee injury, he posted 13 wins with two shutouts in a career-high 34 games last season.

Multiple sclerosis is an incurable autoimmune disease that attacks the central nervous system. There are an estimated 200 new cases diagnosed every week in the U.S., according to the National Multiple Sclerosis Society.

The NHL has locked out its players as the sides try to come up with a new collective agreement. The league has canceled games through Dec. 14, plus the outdoor Winter Classic on Jan. 1 and the All-Star Game on Jan. 27.

To contact the reporter on this story: Mike Buteau in Atlanta at

To contact the editor responsible for this story: Michael Sillup at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.